Bharat Biotech was responding to reports in media about the allegations of graft surrounding the $324-million Covaxin contract signed by Brazil, which has since been suspended by that country.from Moneycontrol Business News https://ift.tt/3A67RlQ
Bharat Biotech was responding to reports in media about the allegations of graft surrounding the $324-million Covaxin contract signed by Brazil, which has since been suspended by that country.
Comments
Post a Comment